Research study Program year 2020 Source: CMS Open Payments

Menb Rec 2Nd Gen-038 (V72_72)

Research payments

$357,322

119 payments

Through program year 2020, $357,322 in research payments was reported against Menb Rec 2Nd Gen-038 (V72_72), across 119 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2020	Research	$357,322	119

Breakdown

Who paid Research payments · program year 2020

GlaxoSmithKline, LLC. $357,322 119 payments

Who received the money Research payments · program year 2020

Pharmaceutical Research Organization Organisation paid for research $87,236 30 payments
J Lewis Research INC Organisation paid for research $70,095 28 payments
Multicare Institute For Research And Innovation Organisation paid for research $43,510 9 payments
Clinical Neuroscience Solutions INC Organisation paid for research $30,997 13 payments
Boeson Research LLC Organisation paid for research $21,222 9 payments
Blue Grass Clinical Research INC Organisation paid for research $19,624 8 payments
Kentucky Pediatric And Adultresearch Organisation paid for research $19,125 2 payments
Lung Diagnostics Ltd Organisation paid for research $18,900 3 payments
Alliance For Multispecialty Research Organisation paid for research $10,966 5 payments
Dayton Clinical Research Organisation paid for research $8,934 6 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.